Harmonizome 3.0

Spinal muscular atrophy, chronic distal, autosomal recessive

spinal muscular atrophy, congenital nonprogressive, of lower limbs

Spinal muscular atrophy, Jokela type

muscular dystrophy, with rimmed vacuoles

muscular LMNA-interacting protein

Predicted to enable lamin binding activity and transcription corepressor activity. Predicted to be involved in negative regulation of cardiac muscle hypertrophy in response to stress; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription by RNA polymerase II. Predicted to be located in PML body; nuclear envelope; and sarcolemma. [provided by Alliance of Genome Resources, Mar 2025]

limb girdle muscular dystrophy 1H (autosomal dominant)

limb girdle muscular dystrophy 1G (autosomal dominant)

Muscular dystrophy, congenital, 1B

facioscapulohumeral muscular dystrophy 1A

Facioscapulohumeral muscular dystrophy (FSHD) is a common hereditary disease of muscle. Patients with FSHD have a chromosomal rearrangement within the subtelomeric region of chromosome 4 (4q35). This region is composed mainly of a polymorphic repeat structure consisting of 3.3 kb repeat units, designated D4Z4. The number of repeat units varies from 10 to more than 100 in the population, however, in FSHD patients only 1-10 repeat units is observed because of a deletion of an integral number of these units. FSHD is caused by an epigenetic mechanism involving the contraction of a subtelomeric macrosatellite repeat, which results in marked hypomethylation of the contracted D4Z4 allele. It is likely not the structure, but the deregulation of transcription of one or more genes as a result of repeat-contraction-mediated chromatin alterations, that causes FSHD. [provided by RefSeq, Sep 2011]

facioscapulohumeral muscular dystrophy 1B

spinocerebellar ataxia 18 (sensory with neurogenic muscular atrophy)

muscular dystrophy, congenital, merosin-positive